Postmenopausal Hormone Therapy and Risk of Cardiovascular Disease by Age and Years Since Menopause

Jacques E. Rossouw(Baylor College of Medicine), Marcia L. Stefanick(Stanford University)

JAMA

April 3, 2007

10.1001/jama.297.13.1465

Cited by 1,714

Related Papers

Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer

|New England Journal of Medicine|2006|985

Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial

|JAMA|1995|605

Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women

|JAMA|2010|565

Breast Cancer after Use of Estrogen plus Progestin in Postmenopausal Women

|New England Journal of Medicine|2009|468

Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials

|JAMA|2020|412